Navigation Links
Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400

SANTA CLARA, Calif., March 7 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the first TruBio(TM) OS plug-in for OPC connectivity between TruBio(TM) OS and Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies confirmed that a TruBio(TM) OS plug-in for OPC connectivity to the Nova Flex is currently in development.

OPC (Openness, Productivity and Collaboration) has become the de facto standard for data exchange in process control systems. It has been adopted by the majority of the control system manufacturers in the bioprocess industry and has proven to be a reliable method for sharing information across different hardware platforms.

Automatic data exchange using OPC between a lab analyzer and control system reduces errors and time delays of manual sampling, and provides automated reporting of results. It also allows the control system to adjust process parameters without a 24/7 operator presence, and, in the event of process alarm conditions, alerts off-site personnel and/or takes automatic corrective action.

This level of integration enables direct consolidation of off-line lab analyzer results into existing historical data collection, automates batch report generation, and creates a complete electronic record. Printouts of standalone analyzer results do not have to be manually attached or tracked with electronic batch reports that control systems already provide.

"Taking advantage of OPC connectivity between Nova analyzers and the Finesse bioprocess control system will improve quality and yield, while reducing operating costs. For example, programming a Nova analyzer to automatically standardize an in-situ probe, or using the resulting sample data in real-time control algorithms, will increase both process understanding and control accuracy," stated Dr. Mark Selker, CTO and co-founder of Finesse.

"By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability. The value lies in the actions upon that information. Nova and Finesse provide the compliment to each other's technologies thereby allowing our customers real-time benefits that, until now, were impossible," says Bob Fox, Director of Sales.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.

SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Finesse Solutions Expands by Opening Sales and Service Centers
2. Finesse Introduces TruBio(TM) IOQ
3. Cascade Microtech Introduces Worlds First 45 nm-capable DC/RF Parametric Probe Card Solutions, Lowers Cost of Ownership
4. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
5. Senetek PLC Announces Appointments of Key Personnel
6. Iomai Announces Year-End 2007 Financial Results and Business Progress
7. Dragon announces new product launch; increase in annual production output capacity
8. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
9. China Yingxia International Announces Q4 and FY 2007 Estimates
10. Bristol-Myers Squibb Announces Dividend
11. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):